The global market for cerebrospinal fluid (CSF) management is anticipated to reach USD 2.31 Billion by 2028, with a projected revenue CAGR of 4.8% throughout the forecast period. The market's growth is fueled by several significant factors, including the rising number of individuals affected by neurological diseases, a surging demand for minimally invasive surgical procedures, and the rapid...